Gastro Medical News about Liver

Your Unread Messages

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Xenobiotic-Sensing Nuclear Receptors CAR and PXR as Drug Targets in Cholestatic Liver Disease
Current Drug Targets, 11/03/09

Kakizaki S et al. – CAR and PXR have a protective effect on cholestasis by activating both detoxification enzymes and transporters. As a result, novel compounds targeting CAR and PXR with specific effects and fewer side effects will therefore be useful for the treatment of cholestatic liver diseases. This article will review the current knowledge on xenobiotic–sensing nuclear receptors CAR and PXR, while also discussing their potential role in the treatment of cholestatic liver diseases.

<< Previous
Impact of Virtual Imaging Procedures on Treatment Strategies in...

Next >>
Hospital prices climb 0.2% in September

Simplifying hepatic venous outflow reconstruction in sequential living donor liver transplantation
Liver Transplantation, 10/30/09 Relevance Score: 95%

Liver Regeneration in 120 Consecutive Living-Related Liver Donors
Transplantation Proceedings, 11/05/09 Relevance Score: 94%

A knowledge-based technique for liver segmentation in CT data
Computerized Medical Imaging and Graphics, 10/27/09 Relevance Score: 93%

Statin therapy initiated in a man with hepatitis C and elevated cholesterol
The Clinical Advisor, 10/07/09 Relevance Score: 93%

Recognizing and treating cutaneous signs of liver disease
Cleveland Clinic Journal of Medicine, 10/05/09 Relevance Score: 93%